This is a public database of research institutions and projects that want to host science journalists for their FRONTIERS Residencies.
The Hosts Database contains expressions of interest received by the FRONTIERS Team and these are a great starting point for applicants. However, an institution does not have to be in this Database to be eligible as a host institution. Journalists are encouraged to do their investigation and contact the research institutions that best fit their project.
If you have any questions or feedback about this database, please check out the FRONTIERS Program Guide and Frequently Asked Questions pages, or write to support@frontiersmedia.eu.
-
Luxembourg Centre for Systems Biomedicine
The Luxembourg Centre for Systems Biomedicine (LCSB) was founded in 2009 as one of the first interdisciplinary research centres of the University of Luxembourg. Our staff members combine their expertise in a broad spectrum of disciplines – from computational biology to clinical and experimental neuroscience – to study the brain and its diseases.
The LCSB aims to gain a mechanistic understanding of neurodegenerative processes and to use the resulting knowledge to develop new ways to diagnose, prevent and treat neurodegenerative disorders, like Alzheimer’s and Parkinson’s. To realise this vision, we conduct research in the field of Systems Biology and Biomedicine – in the lab, in the clinic and in silico (computer modelling and simulations).
Read MoreFor over a decade, the LCSB has established a state-of-the-art infrastructure and developed skills in several fields, such as genetics, metaproteomics, enzymology and cheminformatics. We foster interdisciplinarity because we strongly believe that complex problems can only be solved when the best minds from different disciplines come together and form a team.We work together with scientific partners worldwide and carry out collaborative projects with research-oriented companies and hospitals, to accelerate the translation of research results into clinical applications and to tackle the growing issue represented by neurodegenerative diseases worldwide.
Research DomainContact PersonSabine Schmitzsabine.schmitz@uni.luHosting ConditionsThe LCSB is located on campus Belval, in the south of Luxembourg, close to France, Belgium and Germany. New buildings and the industrial heritage of the blast furnaces combine into an innovative campus, including a stunning university library. The campus is easily accessible as public transport is free in Luxembourg. We will provide science journalists with a desk in our building as well as access to shared areas. Our communication team will work in collaboration with the university press office to introduce science journalists to different research teams and to organise visits. Thanks to the LCSB dynamic work culture, scientific seminars and networking activities will also happen on a regular basis, showcasing the multidisciplinary and multicultural environment typical of the LCSB.
-
Biomedical Research Center of the Slovak Academy of Sciences
The challenges of human health and diseases are very complex and the Biomedical Research Center of the Slovak Academy of Sciences is able to look at them from different perspectives, as it comprises five areas of biomedical research: experimental endocrinology, experimental oncology, virology, neurobiology as well as clinical and translational research. The Biomedical Research Center is a multidisciplinary institution of basic and translational research. We focus on the study of human disease mechanisms and their interactions and on the development of new preventive, screening and diagnostic approaches that are not yet available in current medical practice in Slovakia. We aim to contribute to the explanation of the causes, mechanisms and consequences of metabolic, neurobiological, neuroendocrine, autoimmune, cardiovascular, oncological and infectious diseases and to develop new strategies for combating these diseases, that represent a great health, social and economic burden on our society.
Read MoreResearch projects
– experimental oncology – study of environmental, genetic, epigenetic and (patho)physiological mechanisms of carcinogenesis and cancer progression,
research and development of new approaches to cancer prevention, diagnosis and therapy.
– experimental endocrinology – research in the fields of endocrinology, neuroendocrinology and psychiatry, cardiology, exercise physiology and integrative (patho)physiology of metabolic disorders, as well as genetics and DNA diagnostics of rare disorders with focus on direct translation into the clinical practice. – – virology – research on epidemiology, pathogenesis and immunology and of viral and rickettsial infections, research and development of new diagnostic and therapeutic approaches, development of analytical methods for practice.
-neurobiology – research of central nervous system focused on vascular and traumatic disorders, mechanisms of injury, neuroprotection, and new approaches to regeneration of nerve tissue.S. Pastorekova: Role of the CA IX ectodomain in tumor growth and metastasis
B. Smolkova: Identification of biological markers for prevention and translational medicine in pancreatic cancer
J. Ukropec: Molecular mediators of the response to complex lifestyle intervention in patients with obesity: Regulation of metabolic flexibility in vitro and in vivo
B. Ukropcova: Ameliorating Effects of Aging by Physical Exercise: Molecular, Metabolic and Structural Adaptations, Multi-Organ Integrative Approach
B. Klempa: Zoonoses Emergence across Degraded and Restored Forest Ecosystems (ZOE).Research DomainContact PersonEla Rybárováela.rybarova@savba.skHosting ConditionsAn individual desk is available, and there is a press officer. Our team is mostly working in the office (four institutes are based in Bratislava, one is in Kosice). Access to canteen
-
Babraham Institute – Ageing research for lifelong health
The Babraham Institute is a centre for discovery research in human biology with a view to understanding how our bodies work and what changes with age and disease. As a pioneering fundamental life science institute, our overarching aims are to understand the human biology that underpins health. Our research provides the bedrock for interventions that promote health and tackle age-related decline, thereby maximising heath span – the numbers of years lived in good health.
Our 20 research groups, grouped by area of focus into three research programmes: epigenetics, signalling and immunology, possess expertise in defining the molecular and cellular details that determine cell identity, human development, the effect of diet on health through epigenetic mechanisms, how our immune systems develop and respond to threats, the effect of age on the function of the immune system, protein quality control, the biology of protein aggregation, cellular recycling and cellular fitness.
Read MoreOngoing research in specific pioneering areas includes:- Exploring new paradigms for cellular signalling (Host researcher: Maria Christophorou)
- Investigating the acquisition of drug resistance in fungal pathogens (Host researcher: Jon Houseley)
- Studying protein aggregation (several research groups in the Signalling research programme)
- Dissecting how the pace of development is set in different species (Host researcher: Teresa Rayon)
- Overcoming the effects of age on the immune system (several research groups in the Immunology research programme)
The research of the Institute is underpinned by eight cutting-edge scientific facilities. The equipment and the expertise of the facility teams enable our researchers to ‘think big’, taking new approaches to make discoveries and advance our knowledge of biology. We have a tradition of pioneering new research techniques that take science forward.
Our work provides the foundation for more applied, commercial bioscience. Our co-location with the 60 life science companies on the Babraham Research Campus provides the perfect environment for entrepreneurship, collaboration and innovation as we work to accelerate the application of our discoveries for societal benefit. Our partnerships with academic and commercial bioscientists allow better science to happy more efficiently on both sides. In addition to joining the Institute’s community, a journalist in residence would also have exposure to the campus community, exploring knowledge exchange at the interface of academic and commercial research.
The Institute has a long history of discovery research and our research is classed as internationally leading. Our 20 research groups, working across three themes, bring curiosity, bold scientific ambition and expertise to undertake pioneering discovery research. Our approach focuses on cellular and molecular biology working in several model systems (fruit flies, nematode worms, cell cultures, mice, human samples). This research is enabled by the Institute’s cutting-edge scientific facilities (bioinformatics, biological chemistry, biological support unit (small animal unit), flow cytometry, gene targeting, genomics, imaging, mass spectrometry) and achieved by innovation from our research teams who develop techniques to provide novel biological insights.
Our findings advance our understanding of human biology and generates the essential biological knowledge that provides the platform for lifestyle and healthcare interventions.
Scientific progress has driven incredible advances in recent centuries and life expectancies are higher than ever before. Yet improvement in healthy life span – the time when we’re still fit and active, often called health span – has been minimal. Almost 1 in 5 people in the UK are now over 65 years old and that proportion is rising. By studying how cells in our body specialise, regulate their genes, communicate and defend themselves against illness, we hope to gain insights into why we age, why some of us age faster than others and how we can stay healthy for longer.
The biology of ageing is generally not well understood, so we take a fundamental approach to understanding how our bodies change as we age. It’s not yet possible to directly intervene in the human ageing process. Instead, we use a combination of cell culture, animal models, organoids, and computational models to examine and understand the basic principles of biological ageing.
Many major illnesses including cancer, diabetes and heart disease become more common with age. Older people are also much more prone to contagious diseases such as flu. By understanding ageing, we can lay the foundations for ways to revitalise ageing systems in our bodies, which could greatly reduce the number of cases of diseases like these and many others.
Research DomainContact PersonLouisa Woodlouisa.wood@babraham.ac.ukHosting ConditionsA journalist in residence at the Institute will have numerous opportunities both on campus and within the wider Babraham Research Campus. They will have all necessary resources and support from several teams to explore their focus area. With guidance from the FRONTIERS manager, they can discuss, observe, and join research discussions. The fellow can attend seminars and events featuring distinguished speakers and work dynamically with research groups while having a base with the Communications team. They will receive a visitor status badge for campus access and assistance from the Information Librarian, including journal access. On-site amenities include a cafeteria, subsidized gym, yoga sessions, and optional accommodation. Beyond the Institute, they can engage with commercial research and innovation on campus and participate in Cambridge-led initiatives. The Institute fosters an inclusive and supportive environment for life science research.
-
Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)
The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases, it also damages the microbiome as a whole.
CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.
Read MoreThe Cluster of Excellence CMFI brings together researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.The CMFI is one of more than 50 Clusters of Excellence funded by German federal and state governments as part of the Excellence Strategy to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.
Research DomainContact PersonLeon Kokkoliadisleon.kokkoliadis@uni-tuebingen.deHosting ConditionsThere will be an individual desk and access to our research buildings. The journalist will be supported by the press office regarding information about research directions at CMFI, suitable host researchers. Most of the CMFI members are working in the office/lab.
-
Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING)
The Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING) was established through the efforts of Amalia Koutsouri-Fleming, a microbiologist and wife of Alexander Fleming, the Nobel Laureate 1945 in Medicine. She had the vision for a Greek Center of Scientific and Technological Excellence, based on meritocracy, excellence and innovation purposed to attract and develop young Greek researchers.
Read More
BSRC FLEMING started its operation in 1999 and is nowadays a top-ranked non-profit research organization of 23 group leaders and 130 researchers, with a mission to perform cutting edge basic and translational research in biomedical sciences, provide state-of the-art training and mentorship to scientists and students of all levels, offer high end scientific and technological services, and engage in technology transfer and innovation. The center is located in an area of 128.000 sq.m. in Vari, a region on the Athenian Riviera. The Fleming Museum of Contemporary Science is also housed on the premises of the research center.Its main research directions include Immunity & Inflammation, Neuroscience, Cancer Biology, RNA Biology & Epigenetics, Bioinformatics & Computational Biology. Additionally, BSRC FLEMING has recently established its frontier research in Biomolecular Engineering & Synthetic Biology with a European Research Area chair (ERA Chair), Dr. Georgios Skretas. These research directions reflect the work of its group leaders and serve as links between the two FLEMING Institutes: Institute for Bioinnovation (IBI) and Institute for Fundamental Biomedical Research (IFBR). The focus of IFBR is on unravelling the molecular and cellular basis of disease via novel animal models of human pathologies, while IBI’s vision is to advance fundamental research achievements towards innovative translational biotechnologies and drug development.
BSRC FLEMING’s strength and international recognition arises from pioneering research towards understanding the molecular and cellular basis of human diseases, and development and validation of relevant animal models of chronic inflammatory diseases, neurodegenerative disorders, metabolic diseases, cancer and autoimmune syndromes, among others, and the development of new approaches for their diagnosis and treatment, using transdisciplinary approaches and state-of the art facilities and technologies. It is of note that several of its researchers have been included in the list of outstanding research leaders in Europe awarded ERC grants.
The center also coordinates two major Research Infrastructures (RIs) for modeling human diseases and bioinformatics/biocomputing resources, while it participates in personalized medicine, precision oncology and bioimaging RIs.
Research DomainContact PersonStadia Politipoliti@fleming.grHost InstitutionBiomedical Science Research Center "Alexander Fleming" (BSRC FLEMING)Greece
Hosting ConditionsThe Journalist in residence will have access to all BSRC FLEMING premises, including laboratory facilities, shared equipment rooms, shared office and access to meeting rooms and cafeteria during working hours and days (Mon-Fri). She/he will be able to have direct contact with any of the center's researchers depending on the journalism project. The entire staff will communicate with him/her in English. She/he will be able to visit specific facilities, observe research experiments and attend all seminars and events organized by BSRC FLEMING. Transfer to the center is limited. The nearest bus station is 30-35' walking distance. However, the center provides transfer to the bus station once in the morning (approx. 09.00am) and once in the afternoon (approx. 17.00 pm). Other details and specific requirements will be discussed directly with the interested journalists.
-
August Pi i Sunyer Biomedical Research Institute (IDIBAPS)
IDIBAPS is one of the leading biomedical research centers in Spain with an international projection. IDIBAPS is uniquely located in the Campus Clínic in Barcelona, joining efforts with the Faculty of Medicine of the University of Barcelona and the Hospital Clínic of Barcelona to carry out excellent biomedical research and investigate the most common diseases in our society. Our mission is translational research; that is, we look to ensure that the questions that arise at the patient’s bedside find answers in the laboratory and that advances made in the laboratory are translated rapidly to the patient.
Read MoreIDIBAPS research is organized into research areas and multidisciplinary programs.5 Research Areas and 3 transversal groups:
1. Biological aggression and response mechanisms
2. Respiratory, cardiovascular and renal pathobiology and bioengineering
3. Liver, digestive system and metabolism
4. Clinical and experimental neuroscience
5. Oncology and haematology
6. Transversal research groups focusing on primary care, pharmacology and nursingMultidisciplinary Programs:
1. Transitional cancer research program
2. Lymphoid neoplasms program
3. Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience programAmong the multiple research groups, we would like to highlight the following research lines, supported by ERC grants, for the FRONTIERS Science Journalism Residency Program:
– Neuronal control of metabolism directed by Marc Claret, Principal Investigator of MITOSENSING project: https://cordis.europa.eu/project/id/725004
– Cortical circuit dynamics directed by Jaime de la Rocha, Principal Investigator of PRIORS project: https://cordis.europa.eu/project/id/683209
– Molecular pathology of lymphoid neoplasms directed by Elías Campo, Principal Investigator of BCLLatlas project: https://cordis.europa.eu/project/id/810287Research DomainContact PersonDaniel Arbósidibaps.comunicacio@recerca.clinic.catHosting ConditionsThe journalist will have access to IDIBAPS premises, including laboratories and meeting rooms, during working hours on weekdays (Mon-Fri). They will be provided access to the institution's Wi-Fi and online scientific articles. They will be included in the institute's mailing list to stay updated with all relevant news and events. Our institution offers hybrid work options and flexible working conditions; therefore, they will have access to shared desks located in the Communications Office and will be supported and mentored by a member of the Communications Team. Additionally, they will have direct contact with IDIBAPS researchers, visit their laboratories on a rotating basis to observe research experiments, attend scientific discussions, seminars and other social events organized by IDIBAPS.
-
Center for Neuroscience and Cell Biology & Centre for Innovative Biomedicine and Biotechnology
CiBB – Centre for Innovative Biomedicine and Biotechnology, is a Research Center of excellence in the domains of Biomedicine and Biotechnology, which results from a consortium joining CNC-UC — Center for Neuroscience and Cell Biology and iCBR – Coimbra Institute for Clinical and Biomedical Research. In 2024, the Teaming projects MIA-Portugal: Multidisciplinary Institute of Ageing and GeneT – Gene Therapy Center of Excellence have integrated the CiBB multidisciplinary structure.
We can offer an exciting opportunity to delve into the dynamic world of biomedical research and science communication. This fellowship provides hands-on experience in communicating biomedical discoveries through various mediums, including media interactions, video production, and social media management. The FRONTIERS fellows will have the chance to collaborate with an experienced and passionate team, learning and contributing to effective strategies in scientific communication.
Read more
The fellowship allows for direct interaction with top researchers in four distinct areas of biomedicine, providing a comprehensive insight into the latest findings and trends in biomedical research.Furthermore, the work environment fosters a strong culture of science communication, offering fellows a full immersion into the realm of scientific outreach. Fellows will have the opportunity to develop essential communication skills, create engaging content, and broaden the reach of scientific discoveries to the general public. This fellowship is ideal for professionals interested in exploring the intersection of science, journalism, and digital communication while collaborating with a multidisciplinary and inspiring team.This offers an immersive experience within the vibrant ecosystem of CNC-UC / CiBB, providing fellows with unique access to the forefront of biomedical research and science communication. Fellows will be fully integrated into the CNC-UC / CiBB community and will have the opportunity to attend weekly scientific seminars and thematic retreats, gaining invaluable insights into cutting-edge research across various biomedical disciplines. They will actively participate in the institution’s science communication dynamics, engaging in various outreach activities and gaining access to scientific platforms to observe experiments and scientific endeavors firsthand.
More about CiBB
With the largest critical mass of researchers in the Centre Region of Portugal, internationally recognized and linked to the Faculties of Pharmacy, Medicine, Sciences and Technology and Economics, as well as to the Institute of Interdisciplinary Research and to the Coimbra University Hospital, CiBB has a high-level of scientific production and attracts talent and funding at national and international levels.The CiBB stands as the flagship of Biomedical and Biotechnology Sciences at the University of Coimbra (UC). It is the largest R&D Unit in the center region of Portugal and the sole UC-coordinated Associate Laboratory (top 100% evaluation), welcoming circa 700 members.
CiBB comprises 37 dynamic and multidisciplinary research groups, dedicated to understanding how and why diseases develop, particularly those associated with aging, and translating this understanding into clinical applications and technological breakthroughs.
Structured around four thematic pillars, CIBB’s mission spans diverse areas:
1. Neuroscience and Disease: Delving into brain function and dysfunction in disorders such as neurodegenerative diseases, neuropsychiatric conditions, and vision impairments.
2. Metabolism, Aging, and Disease: Investigating the cellular and molecular underpinnings of metabolic dysfunction and aging, and their impact on age-related diseases.
3. Innovative Therapies: Harnessing the potential of stem cells, genetic interventions, and pharmaceuticals to pioneer new treatments for neurodegenerative, cardiovascular, oncological, and infectious conditions.
4. Healthcare Challenges: Tackling healthcare challenges by promoting evidence-based decision-making, engaging citizens, and finding innovative solutions for aging-related questions.
CiBB is committed to nurturing talent, through robust international training programs at the master’s and doctoral levels. Additionally, CiBB bridges the gap between research and society through effective communication and public engagement initiatives.
In collaboration with the Coimbra University Hospital and its Clinical Academic Center, CiBB leverages its strong ties to clinical practice, facilitating the translation of fundamental research findings into clinical benefits. Moreover, CiBB invests on the transformation of scientific breakthroughs into intellectual property, fostering technology transfer and the creation of economic value.Note: We are open to developing projects that encompass a broader scope, involving communication across different areas of the center, and/or focusing on specific ongoing research projects within the center.
Research DomainContact PersonSara Varela Amaralsara.amaral@cnc.uc.ptHosting ConditionsFellows will have the chance to interact with a diverse range of researchers and contribute to both national and European research projects. They will be included in the institution's mailing list, receiving regular updates and news about the CNC-UC / CiBB community. Additionally, fellows will be granted a dedicated profile page on both the CNC-UC and CiBB websites to showcase their work and contributions. Fellows will be provided with a dedicated workspace and have the flexibility of hybrid work arrangements, combining in-person and remote work as needed. They will have access to University of Coimbra facilities, including cafeterias, bookstores, and recreational amenities. The University of Coimbra offers numerous opportunities for sports and cultural activities, allowing fellows to enrich their experience beyond the confines of their fellowship duties.
-
Leibniz Institute for Natural Product Research and Infection Biology
We dedicate our research to natural products from micro-organisms and the infection biology of pathogenic fungi. Microbial natural products serving as mediators in the biological communication are essential for our lives. However, they play an ambivalent role in this process: On the one hand, they are involved in the emergence of numerous infectious diseases; on the other hand, they belong to the most important sources of medicinal products like antibiotics.
Read MoreIn order to examine microbial natural products and to understand infectious diseases better, we combine both areas of research. We aim to elucidate how microorganisms produce both pathogenic substances and pharmacologically relevant components. Beyond that, these substances of micro-organisms serve as instruments of communication among themselves. Another module of our research is the interaction of pathogenic microorganisms with their host. We are interested in investigating the methods and tricks that both parties use in this process.Numerous individual joint projects enable us to acquire new knowledge in the field of biosynthesis and the function of natural products. We use this knowledge to develop innovative ingredients for the diagnosis and therapy of illnesses, including new anti-infectives. Implementing our research results and the models derived thereof, we contribute to the development of a systems biology of infections.
Research DomainContact PersonFriederike Gawlikfriederike.gawlik@leibniz-hki.de -
Leibniz Institute for Prevention Research and Epidemiology – BIPS
The Leibniz Institute for Prevention Research and Epidemiology – BIPS develops effective strategies for the prevention of chronic, non-communicable diseases. Supporting a healthy life-course early on is our primary goal. The focus of our research is therefore on factors beyond individual diseases, such as lifestyle and environment, biological and social factors, as well as early detection and drug safety. Our research spectrum covers methodological development, the identification of the causes of diseases, and intervention and implementation research. We also offer information to politicians and the general population and provide academic qualification to young scientists. BIPS thus covers the entire cycle of epidemiological research.
Read MoreUnder the central theme of “population-based prevention research in the life-course,” the institute conducts interdisciplinary epidemiological health research on the national and international level. It develops innovative methods and utilizes diverse data sources to study significant health disorders and to evaluate preventive measures and strategies. In addition, BIPS significantly contributes to the establishment of research infrastructures of national and international importance. To this end, BIPS is also committed to the expansion of research data management and the FAIRification of research data as an important basis of Open Science and Open Data.For many years, strengthening prevention has been a key scientific, social, and political objective. BIPS is dedicated to achieve this goal with high-quality research based upon methodological research investigating epidemiological questions with a focus on the development of epidemiological and statistical methods. The institute emphasizes the particular importance of the life-course perspective for the health of individuals and the population as a whole with its focus on long-term studies. Research at the institute provides important insights to ensure and improve health and well-being with measures that begin early and are related to transition periods within the life-course.
Research DomainContact PersonRasmus Cloescloes@leibniz-bips.deHost InstitutionLeibniz Institute for Prevention Research and Epidemiology – BIPSGermany
Hosting ConditionsEach FRONTIERS fellow will be provided with an individual office/desk, equipped with the necessary amenities for a comfortable and efficient working environment. We boast a dedicated press office with a team of 4 professionals. Our press office is experienced in working with journalists and researchers alike, ensuring that you have the support needed for your reporting and research endeavors. Our team operates on a hybrid work schedule, with three days in the office and two days working remotely. Fellows will have 24/7 access to the premises, ensuring that you can work according to your own schedule and pace. Whether you're an early bird or a night owl, our facilities will be open to you. While we do not have an on-site cafeteria, we offer well-equipped cooking facilities for those who prefer to prepare their meals. Additionally, our institution is surrounded by a variety of dining options to cater to diverse tastes and preferences. Fellows will have access to our extensive library, housing a wealth of academic literature, journals, and publications. Furthermore, you will be granted access to a range of online resources to aid in your research and reporting. Recognizing the importance of coffee in fueling research and journalism, we ensure there is a steady supply of coffee available for all.
-
Leibniz Institute for Immunotherapy (LIT)
The Leibniz Institute for Immunotherapy (LIT) develops innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation. By reprogramming immune cells through synthetic and pharmacologic intervention, we build cells that save lives.
Our scientific activities are structured into three Research Areas: Discovery, Translation, and Clinical Application. All three work in synergy with one another. Our work starts with basic research into the areas of immune regulation, immune metabolism, cancer, and tissue homeostasis. It carries on with a focus on therapy development—spanning the creation of new formats of genetic and pharmacologic cell manipulation and drug-compliant manufacturing processes. Finally, we seek to apply our discoveries in early clinical trials on patients themselves.
Read MoreDiscovery: This branch of research investigates the highly complex interactions of different immune cells—with each other and with the organism’s cells—to understand how the immune system maintains the health of the organism.
Translation: This area focuses specifically on the preclinical development of immune-cell therapeutics. This includes the identification, differentiation, expansion, and preclinical testing of therapeutically relevant immune cell populations.
Clinical Application: At the LIT, our core focus is on the clinical translation of scientific findings: We therefore place significant emphasis on the development and roll out of clinical trials and focus on the clinical implementation of the results.
Research DomainContact PersonKerstin Wildkerstin.wild@ukr.deHosting ConditionsAt the LIT a journalist will have a working space with access to wi-fi. Access to LIT is possible 24/7 with a personal electronic device and a name badge. All electronic resources (books, scientific journals and databases), events and activities organized for the institution’s staff, the cafeteria and canteen will be accessible for a visiting journalist. PR & Media Relations staff will support the visiting journalist. The LIT staff is international and official language in our institution is English!
-
Reinforcing under-utilised crops at the Portuguese living lab GPeaPort – The DIVINFOOD project
In Europe, an increasing number of consumers are embracing plant-based diets and reducing meat consumption. A 2021 survey found that around 30% of Europeans follow a flexitarian diet, focused on plant-base foods with occasional meat consumption. This dietary trend underscores the demand for improved, minimally processed, and nutrient-rich alternatives.
Read More
The DIVINFOOD project aims to develop food chains that value under-utilised agrobiodiversity, in order to act against the decline of biodiversity and meet the growing expectations of consumers for healthy, local products that contribute to sustainable food systems. DIVINFOOD operates holistically across the food chain, fostering collaboration among researchers, farmers, processors, market intermediaries, and consumers, to maximize cereals and legumes food chains, realizing their potential for diversified and healthy diets.Funded under the European Commission Horizon 2020 Sustainable Food Security call, DIVINFOOD boasts a consortium of 25 European institutions led by the Institut national de recherche pour l’agriculture, l’alimentation et l’environnement, in France, with four Portuguese partners: ITQB NOVA, Évora University, ADECA and Cooking lab. In Portugal, the project focuses on grass pea (Lathyrus sativus).
Carlota Vaz Patto coordinates the ITQB NOVA team engaged in DIVINFOOD, specifically the PlantX Lab. With a history of participatory research with local grass pea farmers in Alvaiázere, Portugal, the team has expanded its scope under DIVINFOOD to include a wider range of farmers and processors, establishing the Portuguese living lab, GPeaPort, under her coordination. Living labs are user-centric innovation systems that foster co-creation, integrating research and innovation within community contexts. GPeaPort aims to revitalize and value grass pea cultivation and use by enhancing varietal diversity and developing innovative food products with local food producers, consumers, chefs, cooks, small-scale processors, rural development associations, local authorities and researchers, using a citizen science approach.
At ITQB NOVA, the Genetics and Genomics of Plant Complex Traits (PlantX) Laboratory, led by Carlota Vaz Patto, specializes in molecular quantitative genetics applied to plant breeding. The lab focuses on identifying genes controlling complex interesting traits, such as disease/drought resistance or seed quality, to develop control models, scientific methods and molecular tools to assist precision breeding programs. Within the scope of DIVINFOOD, PlantX hopes to contribute to the diversification of grass pea production systems, through the improvement of its traditional varieties – boosting tolerance to drought, enhancing nutritional quality, and increasing production capacity. They hope to contribute, in collaboration with other Portuguese stakeholders, to diversify diets, by facilitating the implementation of alternative mild processing methods to obtain innovative food products.
Research DomainContact PersonRenata Ramalhorenata.ramalho@itqb.unl.ptHosting ConditionsThe science journalist will be given credentials to access ITQB NOVA premises 24/7, including access to the cafeteria and canteen and other shared areas, such as the library. The journalist will have a dedicated desk and laptop computer with Wi-Fi access and will be able to use the institute’s printers and other resources. ITQB NOVA has a Communication office with whom the science journalist can collaborate with at all times, creating mutual learning opportunities. The journalist is also welcome to participate in all relevant events open to the staff, including seminars, training and networking activities and to take part in social and cultural events. The PlantX lab comprises eight researchers, including postdoctoral researchers, PhD and MSc students, each pursuing their specific projects. They will be readily available to meet with the visiting journalist, sharing their perspectives on science and demonstrating that frontier science is inherently collaborative, requiring concerted and dedicated efforts to validate or falsify the hypotheses under study.
-
State Museum of Natural History Stuttgart
The aim of SMNS research is to comprehensively understand changes in biodiversity at all levels – from genetic diversity to the diversity of species and communities to the level of ecosystems – over geological timescales. SMNS investigates how the diversity of organisms, species communities and interactions has developed in the course of evolution, discerning patterns of change over time and which biotic and abiotic environmental drivers are responsible for this. The SMNS investigates both evolutionary and anthropogenic influences on biodiversity across different temporal and spatial scales.
Read MoreOur expertise encompasses a wide variety of organisms, from charismatic Indonesian tarsiers under threat of extinction to thermophilic neophytes that have spread rapidly and conquered new habitats in the past decades in response to rising temperatures. From giant fossil marine reptiles that were dreaded top predators of the Jurassic Sea to millimeter-sized parasitoid wasps that lay their eggs in other insect larvae, preventing agricultural pests. With more than 12 million specimens in our collection and cutting-edge facilities, we investigate this diversity to unravel the uniqueness of each specimen. It is the fascinating stories behind each specimen that we convey not only in scientific articles but also to our visitors in the exhibition. Be it the first evidence of cancer from 240 million years ago, the predation among giant marine reptiles, as evidenced by bite marks or how the evolution of mouthparts contributed to the diversity we see in some hyperdiverse insect groups.
Through close collaborations, such as with the particle accelerator at KIT, we are able to use synchrotron radiation to create three-dimensional models of insects trapped in amber millions of years ago or visualize the behavior of live parasitoid wasps moving in their host.
We regularly carry out expeditions and paleontological excavations. Both in the vicinity, where many world-famous fossil deposits are easily accessible and also worldwide, with many highly important findings. They range from small, such as the oldest fossil hummingbird to the probably heaviest animal that ever lived on earth: Perucetus colossus. Our scientists describe new species from the meadows and forests in the area where most people would not expect to find the unknown. But also from remote areas such as cave systems across Europe, tropical rainforests or the islands of New Caledonia. We do this together with institutions and researchers from the area and maintain close collaborations that allow for capacity building and vice versa knowledge exchange on an eye level. We are active members in several networks, through which we are able to join forces with other natural history museums, universities and research institutions of all kinds to conduct large-scale projects, such as the German Barcode of Life.Research DomainContact PersonPeter Warthpeter.warth@smns-bw.deHosting ConditionsHosted journalists will be given general access to premises and ressources like guest researchers. Access to the exhibition building will be regularly available during opening hours and to the research building from 7 am to 9 pm. Access to the collections and additional times can be arranged for. A basic workspace including IT equipment will be at your disposal. Wifi is accessible in most parts of the building and this includes automatic online access to scientific journals. The library is well equipped and openly accessible in the research building. There is no cafeteria per se, but the restaurant in the exhibition building offers a discount. SMNS has a guest room to host you onsite but due to high frequentation needs to be reserved ahead. SMNS researchers mostly work on site and interact actively, but solutions for working remotely or in hybrid environments are offered according to individual preferences and living conditions. Possibilities to join field work, such as paleontological excavations and expeditions need to be discussed with the leading researchers but are generally welcome.
-
Champalimaud Foundation
The Champalimaud Foundation (CF) was established in 2005 as a worldwide reference for scientific research and clinical practice. Located in a beautiful setting by the Tagus river in the city of Lisbon, Portugal, the Champalimaud Centre for the Unknown (CCU) is a vibrant scientific and clinical institution where hundreds of national and international (+40 EU and non-EU nationalities) scientists, support staff, physicians, and other healthcare professionals work together to investigate fundamental biological processes and search for effective solutions to alleviate the burden of oncological and neurological diseases, while providing state-of-the-art care to patients.
Read MoreResearch, developed within the Champalimaud Research (CR) programmes, is primarily focused on the fields of neuroscience, cancer and physiology. More specifically, 31 groups are dedicated to fundamental and clinical research on topics that range from Brain-wide control of Behaviour and its impacts in Artificial Intelligence /Machine Learning, to the Immune System and the interaction between Neural and Immune Systems and Disease Progression. With a community of ~500 members distributed in two big open labs (somehow similar to big media newsrooms), with access to several technical and scientific facilities, the aspiration of CR is to help scientists reach their full creative potential and to promote collective achievements beyond those reachable by individual scientists or laboratory groups. The legacy of CR will not only be advances in scientific knowledge but advances in the scientific process itself.According to the latest European Research Council (ERC) dashboard, which comprehensively overviews ERC-funded projects, Portugal has secured funding for 165 projects since 2007 and CF leads the list of institutions in Portugal for ERC funding, both in terms of total number of grants and of overall funding. Most of our ERC grants are in Life Sciences but we also have secured grants in Social Sciences and Humanities and in Physical Sciences and Engineering.
Research DomainContact PersonCatarina Ramoscatarina.ramos@neuro.fchampalimaud.orgHosting ConditionsThis residency at the Champalimaud Foundation (CF) will be organised in such a way that the science journalist will be in direct contact with various Champalimaud Research scientists and members of the Communications, Events & Outreach team. During the residency period, the journalist will: 1) be included in the CR mailing list and so updated with all relevant news regarding the centre; 2) be able to visit specific facilities and observe research experiments (arranged with the principal investigator of the laboratory and/or head of the scientific facility/platform); 3) participate in seminars, workshops and regular work discussions; 4) have access to lectures, conferences and other events, including social and community building activities. The journalist will have a desk inside the Communications, Events & Outreach shared offices, and access to CF premises 24/7, including cafeteria, library, a tropical garden and a gym. The official working language at CF is English. Other details and specific necessities will be discussed directly with the interested journalist/s.
-
Biology of Ageing
The Max-Planck-Institute for Biology of Ageing (MPI-AGE) aims to unravel the molecular, physiological and evolutionary mechanisms underlying the ageing process. As we age, many of our body functions decline, often accompanied by the development of complex and chronic diseases such as type 2 diabetes, cancer, cardiovascular, and neurodegenerative diseases. Our mission is to understand how we can intervene to mitigate or even prevent these age-related diseases and pave the way for a healthier ageing. Currently, much of the research at the institute focuses on three topics: the molecular genetics of ageing, the study of the ageing brain, and the role of mitochondria in ageing processes. In addition, research groups are investigating how DNA repair and nutrient sensing influence ageing.
Read MoreTo understand these processes, the institute currently conducts work on four different model organisms: worms, fruit flies, turquoise killifish and mice. The studies on model organisms are in the long term to be linked with comparative studies in humans. To this end, we are examining samples from patients in the clinic and conducting studies on long-lived families.
Host researcher Joris Deelen focuses on the identification of the genetic mechanisms underlying healthy ageing and extended lifespan in humans. Moreover, the Deelen group aims to establish novel human ageing studies in Cologne to identify and validate biomarkers of healthy ageing.Research DomainContact PersonMaren BerghoffMaren.Berghoff@age.mpg.deHosting ConditionsThe MPI-AGE fosters a conducive, collaborative, international and collegial environment, with 300 employees from over 35 countries. The fellow is allocated an individual desk within the office of the press and public outreach team. The press team works part-time and hybrid, offering support and resources as needed. The host researcher Joris Deelen and his team are mainly working on site at the institute. The working language is English. MPI offers amenities such as tea kitchens, a cafeteria (called Minerva's lounge) with employee discounts, meeting rooms and a social room, all accessible to the fellow. The fellow will of course be provided with our internal WiFi, through which they will also have access to the majority of scientific journals and publications. The institute is situated on the campus of the University Clinic Cologne, with cafés, restaurants and supermarkets within walking distance. It will also be possible to pay a visit to the other research institutes on campus. During the settling-in period, the institute's International Office offers assistance with practical matters such as visa applications and accommodation arrangements. For temporary stays, the institute provides six guest apartments nearby. Each Friday, the MPI-Age holds seminars which offer researchers the opportunity to present their work, providing insight into diverse research areas. Moreover, throughout the year, several public events are held, serving as platforms for dialogue between the scientific community and the public. And to clear their heads for new ideas, the Institute's staff also organize social events such as the weekly beer hour, the carnival party and the summer party.
-
Sustainability at the Frontier: Unveiling Nature’s Potential for Health and Food Innovations
Over 50% of the cork produced worldwide comes from Portugal. This material, used for products that range from wine stoppers to the isolation of spaceships, is at the heart of two ERC research grants developed at ITQB NOVA over the last years. The reason is that half of cork’s weight is made up of suberin, a plant polymer with remarkable antimicrobial, anti-biofouling and hydrophobic properties. Suberin can mimic natural processes and offer sustainable alternatives for combating fungal infections, as explored in the project MIMESIS – “Development of biomaterials through mimesis of plant defensive interfaces to fight wound infections”, but also for encapsulation technologies in the food and drug industries, as investigated in SNAIL – “High-performance hydrophobic suberin nanoparticles for the generation of liquid-air biphasic droplets with application in food and therapeutics”. Both projects were led by ERC Grantee Cristina Silva Pereira, head of the Applied and Environmental Mycology lab of ITQB NOVA.
ITQB NOVA is a scientific research and advanced training institute of NOVA University Lisbon. The institute is located in Oeiras, a seaside town with the highest GDP/capita and the most educated population in the country. The institution excels in Molecular Biosciences across diverse disciplines, contributing to societal challenges focused on the well-being of human societies and on the environment.
Read MoreThe vision for the ERC-funded MIMESIS project was to develop wound dressing biomaterials that combine antimicrobial and skin regeneration properties. The research team successfully developed a biocompatible extraction method that preserves the plant polyesters’ antimicrobial capabilities. Building on this success, the team secured an ERC Proof of Concept Grant in 2024, for potential applications in food and therapeutics. This new project, SNAIL, explores the potential of suberin in encapsulation technologies, envisioning a sustainable shield for functional ingredients, such as probiotics and proteins. By transforming plant polyesters into purposeful biomaterials, this work represents a shift away from energy-intensive synthetic production methods, focusing instead on “closing the loop”, supported by the principles of green chemistry and biorefinery.
During the residency, the science journalist is invited to discover this research, which is not only advancing scientific frontiers but also actively contributing to a more sustainable future by having a clear focus and commitment on the translation into tangible innovations. In addition to delving into the project’s intricacies, supported by ITQB NOVA’s cutting-edge facilities, including the largest Portuguese NMR facility, CERMAX, the science journalist will have the opportunity to experience all the intricacies atmosphere of scientific exploration. This encompasses the dynamic journey of discovery, comprising both highs and lows, where breakthroughs are not confined to “Eureka” moments.Research DomainContact PersonRenata Ramalhorenata.ramalho@itqb.unl.ptHosting ConditionsThe science journalist will be given credentials to access ITQB NOVA premises 24/7, including access to the cafeteria and canteen and other shared areas, such as the library. The journalist will have a dedicated desk and laptop computer with Wi-Fi access and will be able to use the institute’s printers and other resources. ITQB NOVA has a Communication office who the science journalist can collaborate with at all times, creating mutual learning opportunities. The journalist is also welcome to participate in all relevant events open to the staff, including seminars, training and networking activities and to take part in social and cultural events. The Silva Pereira group comprises nearly twenty researchers, including postdoctoral researchers, PhD and MSc students, and undergraduates, each pursuing their specific projects, some of which align with the ERC grants. Together, they encompass a wide range of scientific expertise spanning from biology and biotechnology to materials chemistry, with varying levels of scientific maturity. They will be readily available to meet with the visiting journalist, sharing their perspectives on science and demonstrating that frontier science is inherently collaborative, requiring concerted and dedicated efforts to validate or falsify the hypotheses under study.
-
Institute of Biotechnology and Biomedicine (IBB)
The Institute of Biotechnology and Biomedicine (IBB) was created 52 years ago and was the pioneer of Spanish research institutes within a University. The IBB is located on the campus of the Autonomous University of Barcelona (UAB) and was previously known as the Institute of Fundamental Biology. In 2000, the Institute’s approach evolved towards a multidisciplinary and cooperative research in the area of biotechnological applications in biomedicine and consequently the name was changed. In addition, the strategic objectives of the entire unit were also reformulated, in favour of potentiating translational projects aimed at understanding the molecular bases of diseases and generating instruments, mainly drugs and vaccines, to fight them.
Read moreCurrently, the IBB hosts about 150 researchers, including tenured professors from the UAB, senior scientists, postdoctoral and doctoral fellows, master students and technicians. We host 17 research groups organized in 3 scientific programs that cover multiple scientific areas, but with a shared multidisciplinary character. This configuration allows a broad approach to biological problems and facilitates the transfer of scientific results towards the improvement of the well-being of our society. These three main research umbrella topics are: (1) Applied Proteomics and Protein Engineering, (2) Genomics in Evolution and Disease and (3) Response Mechanisms to Stress and Disease
The senior PIs of the IBB are Dr. Ventura, Villaverde, Ruiz-Herrera, Roig, Corchero, Ferrer, Ariño, Pallarès, Barbadilla, Martí, Gibert, Reverter, Yero, Cerdà, Jaraquemada, JM. Lluch, Piñol, Quijada, Cáceres, Daura, Lorenzo, Pividori, M. Lluch and Roher (Director of the IBB), offering experience in Bioinformatics, Cellular and Structural Biology, Genomics, Immunology, Microbiology, Synthetic Biology, Nanobiotechnology and Proteomics. Some areas in which our researchers work are within the fields of diagnostic tools and theragnostics, vaccine development, neurodegenerative disease detection and new treatments, immune disorders, cancer and targeted drug delivery, bacterial virulence and antibiotic resistances, biotherapeutics for several diseases, etc.Research DomainContact PersonMontserrat Solemontserrat.sole.castellvi@uab.catHosting ConditionsThe Journalist in residence will have access to all IBB premises, including laboratory facilities, shared equipment rooms, shared office and access to meeting rooms. He/she will be included in the mailing list of the institute so that he/she is updated with all relevant news regarding the institute and will be introduced to all researcher’s teams. The structure of the institute comprises the administrative officers, the researchers and research support staff and technicians. The current director, as well as the Evolutionary Immunology group leader, is Nerea Roher, who will be the host researcher. Also, the research promoter from IBB will be at the Journalist disposal bringing support in any matter related to science communication and institutional communication channels such as social media and webpage. Our institution provides remote work options and flexible working conditions. Additionally, the Journalist will have access to all UAB central facilities such as the Communication Cabinet or the Patent Office if needed. Also, the fact that IBB is placed within the UAB campus, provides an additional layer of community services and resources that satisfy most needs of the Institute’s researchers. The collaboration with other Institutions of the so-called UAB Sphere, such as hospitals, CSIC institutes or CERCA Institutes provides additional opportunities in terms of access to other researchers and research outputs. In addition, the close vicinity with other research centres, university departments and companies foster the scientific community bonds, enables the creation of multidisciplinary projects and empowers innovation and technology transfer and that can be certainly interesting from a Journalist’s point of view. Besides that, the Journalist will have access to medical services from UAB campus, on-site GYM facilities at a reduced cost, accommodation opportunities, language services and proximity to a vast number of faculties offering a huge range of studies including journalism and communication to strengthen ties with our institution and seek future collaborations.
-
Barcelona Institute for Global Health – ISGlobal
ISGlobal addresses key global health challenges related to infectious diseases, chronic non-communicable diseases, and environmental factors, including climate. We aim to go beyond state-of-the-art by strengthening research within and across our 5 research programmes and promoting innovation and collaboration on methodological issues through cross-faculty knowledge hubs.
The Global Viral and Bacterial Infections Programme aims to reduce the relevant viral and bacterial disease burden by generating knowledge that translates into novel tools and strategies for their prevention, diagnosis, and treatment. It has a multidisciplinary and translational research portfolio ranging from basic science to clinical, epidemiological, and public health-oriented research. It works at various steps of the prevention-treatment cascade for pathogens such as M. tuberculosis, non-tuberculous Mycobacteria, antimicrobial resistant bacteria, other bacteria of public health relevance (pneumococcus, group B streptococcus, etc.), CMV, HIV, arboviruses, and viral hepatitis.
Read moreThe Environment and Health over the Life-course programme conducts high-quality integrative research to expand knowledge on the causes and mechanisms of NCDs. The programme focuses on environmental, radiation, occupational, lifestyle, social, infectious, and genetic risk factors throughout life, from prenatal to late adulthood. Key topics include respiratory, immune, and cardiovascular health, neurodevelopment, and cancer.The Climate, Air Pollution, Nature and Urban Health programme aims to strengthen evidence related to the health effects of climate change and exposures in urban and natural environments and to assess the health co-benefits of climate action. It focuses on factors such as temperature, noise, air pollution, and green spaces, and their effect on a spectrum of health outcomes, including premature mortality, cardiovascular and respiratory health, and cognitive function. Their main methods consist of the assessment of exposure and health impact, epidemiological modelling, and intervention evaluation, complemented by computational modelling of global climate variations, tipping points, and their impact on health.
The Malaria and Neglected Parasitic Diseases programme aims to generate valuable knowledge and expand, through a multidisciplinary approach, the current scientific understanding of malaria, Chagas, and other neglected parasitic diseases (NPD) affecting humans, and their interactions with human and animal hosts and/or vectors.
The Maternal, Child and Reproductive Health programme aims to bridge the know-do gap and support the global efforts to ensure that all women and children, regardless of where they live or are born, have access to quality healthcare services. Its research focuses on developing and assessing the efficacy and effectiveness of maternal and reproductive health interventions through relevant clinical trials and implementation science.
Research DomainContact PersonBeatriz Fiestasbeatriz.fiestas@isglobal.orgHosting ConditionsISGlobal has two campuses in Barcelona -Campus Clínic and Campus Mar- and an office in Madrid. Campus Clinic includes wet labs in a separate building. Each campus is associated to a hospital and to a University (University of Barcelona for Campus Clinic, Universitat del Mar for Campus Mar). The University of Barcelona provides ISGlobal researchers access to its CRAI resource center, which includes a wide array of e-journals in different scientific fields. Our policy is to promote flexible working arrangements that allow staff members to organise their work schedule most efficiently and satisfactorily while meeting their objectives. We have a hybrid model of work in which telework is coordinated with on-site work. In the office, we use a shared-desk system in which you can reserve a table on any campus via the intranet. All tables have a screen and network connection. Each staff must have their personal keyboard and mouse, which they can keep in a locker at the end of the day. To communicate, we all use the Google Suit: Chat and Meet, which are currently all integrated into Gmail. The Frontiers fellow will have access to all our offices and services in both campuses. Upon arrival, we will provide her/him with an ISGlobal Gmail account and will connect her/him with the communications department and the host researchers.
-
Frontiers of Infectious Diseases
The profound impact of infectious diseases on society, notably underscored during the COVID-19 pandemic, accentuates the imperative for in-depth research to comprehend the intricate dynamics of infectious agents. This includes understanding their modes of transmission, the factors within hosts that influence disease outcomes, and the identification of effective intervention strategies. The urgency of this research has been particularly evident during the pandemic, highlighting the pivotal role of scientific investigation in addressing global health challenges.
The Infectious Diseases Research Program at CIC bioGUNE stands as a vanguard in scientific exploration, pioneering an initiative committed to unraveling the complex and dynamic molecular foundations of infectious diseases.
Read moreThe profound impact of infectious diseases on society, notably underscored during the COVID-19 pandemic, accentuates the imperative for in-depth research to comprehend the intricate dynamics of infectious agents. This includes understanding their modes of transmission, the factors within hosts that influence disease outcomes, and the identification of effective intervention strategies. The urgency of this research has been particularly evident during the pandemic, highlighting the pivotal role of scientific investigation in addressing global health challenges.The Infectious Diseases Research Program at CIC bioGUNE stands as a vanguard in scientific exploration, pioneering an initiative committed to unraveling the complex and dynamic molecular foundations of infectious diseases.
Research DomainContact PersonJana Sendra Viscarrojsendra@cicbiogune.esHosting ConditionsIndividual offices/desks equipped with internet connectivity will be provided. The host institution features a dedicated press office, where the team collaborates in a shared workspace, although a hybrid work option is also available. Access to the premises is granted 24/7, and individuals will be provided access to amenities such as the cafeteria, library, online resources, and more.
-
Molecular Frontiers of Cancer
Cancer, a complex group of diseases characterized by uncontrolled cell growth, poses a formidable challenge worldwide. Its impact on society is profound, affecting millions of lives and presenting a substantial burden on healthcare systems. The need for comprehensive research to unravel the intricacies of cancer biology and develop advanced strategies for diagnosis and treatment has never been more crucial.
The Cancer Research Program at CIC bioGUNE is a multidimensional exploration focused on unraveling the complexities of cancer, specifically targeting Prostate, Breast, Colorectal, and Liver cancers.
Read MoreThis program encompasses several crucial research areas:• Molecular Basis of Cancer Progression: Investigating the molecular signatures and signaling pathways that drive the progression of Prostate, Breast, Colorectal, and Liver cancers. Our goal is to identify potential targets for precision medicine and advance the development of tailored therapeutic interventions.
• Precision Medicine in Cancer Treatment: Applying precision medicine approaches to develop targeted therapies for different cancer types. This includes deciphering the genetic and molecular variations that contribute to cancer heterogeneity and tailoring treatments accordingly.
• Biomarker Discovery for Diagnostic Advancements: Identifying and validating biomarkers that enhance cancer diagnostics and prognostics. Through advanced molecular profiling and bioinformatics analyses, we aim to contribute to the development of reliable biomarkers for various cancer types.
Research DomainContact PersonJana Sendra Viscarrojsendra@cicbiogune.esHosting ConditionsIndividual offices/desks equipped with internet connectivity will be provided. The host institution features a dedicated press office, where the team collaborates in a shared workspace, although a hybrid work option is also available. Access to the premises is granted 24/7, and individuals will be provided access to amenities such as the cafeteria, library, online resources, and more.
-
Molecular Perspectives of Rare Diseases
Rare diseases, often referred to as orphan diseases, encompass a broad spectrum of disorders that collectively affect a relatively small number of individuals within a population. These diseases are characterized by their low prevalence, typically afflicting fewer than 1 in 2,000 people. Despite their individual rarity, the cumulative impact of rare diseases is substantial, with estimates suggesting that there are thousands of distinct rare diseases, collectively affecting millions of people worldwide.
Many rare diseases are chronic, debilitating, and life-threatening, often manifesting early in life. Due to their complex and often unpredictable nature, these diseases can lead to significant physical, emotional, and financial burdens on patients and their caregivers. Moreover, the lack of effective treatments exacerbates the challenges faced by individuals living with rare diseases.
Read MoreThe importance of research dedicated to rare diseases lies in its potential to unravel the underlying molecular mechanisms, genetic factors, and cellular processes driving these conditions. Investigating genetic mutations associated with rare diseases provides crucial insights into the fundamental aspects of human biology and the consequences of genetic abnormalities. Understanding the molecular basis of disease progression is essential for developing targeted therapies that can alter the course of the disease, improving the quality of life for affected individuals.The impact of rare diseases research extends beyond the laboratory, directly influencing clinical practice, healthcare policies, and societal perceptions. By identifying potential therapeutic targets, researchers contribute to the development of novel treatment approaches and pave the way for precision medicine tailored to the unique genetic and molecular profiles of individuals with rare diseases. Additionally, advancements in rare diseases research contribute to the broader understanding of biological processes, benefiting the entire field of medicine.
The Rare Diseases Research Program at CIC bioGUNE plays a pivotal role in addressing the challenges posed by rare diseases. By exploring the intricate molecular pathways, genetic factors, and cellular mechanisms associated with rare diseases, the program contributes not only to scientific knowledge but also to the development of innovative diagnostic methods and targeted therapeutic strategies. The societal impact of this research is substantial, offering hope and improved outcomes for individuals grappling with rare diseases and their families.
Research DomainContact PersonJana Sendra Viscarrojsendra@cicbiogune.esHosting ConditionsIndividual offices/desks equipped with internet connectivity will be provided. The host institution features a dedicated press office, where the team collaborates in a shared workspace, although a hybrid work option is also available. Access to the premises is granted 24/7, and individuals will be provided access to amenities such as the cafeteria, library, online resources, and more.
-
CEITEC Masaryk University
Harnessing knowledge of plant biology for crop improvement, infectious diseases; RNA/nucleic acids in health and disease; correlative approaches to connect dynamics and structure of living systems; cancer biology; and brain disorders.
Research DomainContact PersonHalina Jílkováhalina.jilkova@ceitec.muni.czHosting ConditionsThe FRONTIERS fellow will have his/her own desk and a support from a communications lead of the institute who will be able to introduce him/her to other relevant partners in the city of Brno which has a vibrant innovation ecosystem called #brnoregion (see: https://brnoregion.com/cs-en/). The CEITEC Masaryk University communication team works in the office and there will always be someone available to help.